What changes and what stays the same?
We understand that focus raises questions. That’s why we’ve gathered the most relevant answers for you, whether you’re a partner, customer, supplier or other stakeholder of The Pharmacy House and A.forall.
FOR OTHER CUSTOMERS OF A.FORALL
What changes for me as a customer of A.forall?
Almost nothing. Your trusted contacts remain the same. Our teams, agreements and way of working do not change. But there will be the added benefit of an even sharper focus on generics.
Will I notice a difference in services or support?
No. Our service promise stands. The only difference is that we’re now even more aligned behind one mission and we can focus fully on generics.
Is the product portfolio affected?
Only positively. Our full focus is now on generics, which also means a focus on growth. We are working on expanding, in line with our strategy. And when this happens, you’ll be the first to hear about it.
FOR CUSTOMERS OF THE PHARMACY HOUSE
What changes for me as a customer of The Pharmacy House?
You can expect the same high quality as you are used to. All operations, contracts and contact persons will be transferred to Abacus Medicine. Your point of contact remains the same.
Will The Pharmacy House disappear as a brand or service provider?
The Pharmacy House will continue its operations under the Abacus umbrella, supported by the same team and services you rely on today.
Who is Abacus Medicine?
The Abacus Medicine Group has over 1,500 employees and achieved revenue of EUR 1,487 million in 2024. The Group improves global healthcare by providing better access to medicine and recorded sales in 35 countries globally last year. Recognised for consistently delivering profitable revenue growth, the Group continues to invest in scalable digital excellence and being an employer of choice.
The parallel trade division of the Abacus Medicine Group is among Europe’s leading parallel traders of medicine and the largest European independent distributor of medicine by geographical reach.
Why is Abacus a good fit?
Abacus Medicine is a pan-European expert in hospital supply and shortage management. With strong ambitions in Belgium and Ireland, they are well placed to build on the strengths of The Pharmacy House.
FOR SUPPLIERS
What happens if I’m a supplier to A.forall?
You will continue working with A.forall as you do today. The transaction does not trigger any changes to contracts, delivery terms or contacts.
What if I’m a supplier to The Pharmacy House?
Your agreement and relationship do not change, and will remain with the Pharmacy House, which will come under the bigger umbrella of Abacus Medicine, contributing to their huge expertise and network.
ABOUT THE SALE
Why did A.forall sell The Pharmacy House?
Because we believe in focus. The Pharmacy House and our generics division have both grown into strong, independent businesses. Selling one, allows both of them to grow on their own terms, with the right strategy and support behind it.
What will A.forall focus on from now on?
On what we do best: generics. Developing, licensing and commercializing value-added, injectable and high-barrier generics worldwide. In line with our mission: #MakingAffordableMedicinesAvailableToAll
Who is Abacus Medicine?
Abacus Medicine is a pan-European pharmaceutical company, known for its role in hospital supply and parallel imports. With over 1,500 employees and sales in 35+ countries, they are a well-established name in parallel distribution, shortage management and supply reliability.
PRACTICALITIES & TIMING
When will the sale be completed?
The agreement has been signed. The transaction is expected to close before year end, subject to standard completion conditions.
What changes in the short term?
Nothing operational. Both A.forall and The Pharmacy House continue business as is. All staff, systems and contracts remain in place.
What happens in the long term?
Gradually, The Pharmacy House operations will be integrated into the Abacus organization. For A.forall, the focus will shift toward further expanding our generics pipeline, product launches and global footprint.
Who do I contact if I have questions?
You can contact your usual A.forall or Pharmacy House contact. For general questions, you can also reach out to communications@aforallpharma.com
GEOGRAPHICAL & ORGANISATIONAL
What happens with the US operations of A.forall?
We strongly believe in the opportunities the US-market offers. That’s why we have a dedicated team on the ground and continue to invest in licensing, partnerships and long-term presence. The US remains one of A.forall’s strategic priorities. We envisage growth in the near future.
What happens to offices in Ireland and Belgium?
A.forall remains headquartered in Belgium with active offices in Ireland and the U.S. Our international structure and collaborations remain unchanged, with the ambition to grow in the near future.